Botulinum toxin type a 300u (DrugBank: Botulinum toxin type A)
13 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
5 | 進行性核上性麻痺 | 0 |
6 | パーキンソン病 | 0 |
7 | 大脳皮質基底核変性症 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 1 |
15 | 封入体筋炎 | 0 |
17 | 多系統萎縮症 | 0 |
36 | 表皮水疱症 | 0 |
51 | 全身性強皮症 | 0 |
70 | 広範脊柱管狭窄症 | 0 |
113 | 筋ジストロフィー | 0 |
149 | 片側痙攣・片麻痺・てんかん症候群 | 0 |
226 | 間質性膀胱炎(ハンナ型) | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00876447 (ClinicalTrials.gov) | January 1, 2009 | 1/4/2009 | A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis | Overactive Bladder | Biological: Botulinum Toxin Type A 300U;Biological: Botulinum Toxin Type A 200U | Allergan | NULL | Completed | 18 Years | N/A | All | 397 | Phase 3 | United States;Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;Czech Republic |